Market Size, Share, Industry Analysis, Trends, Growth, Forecasts, 2030

Tissue Engineered Skin Substitute Market

Tissue Engineered Skin Substitute Market By Product (Biological, Biosynthetic, And Synthetic) By Application (Chronic And Acute Wounds) By End User (Wound Care Centers, Hospitals, And Others), And By Region - Global And Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2023–2030-

Category: Pharmaceutical Report Format : PDF Report Code: ZMR-6261 Status : Upcoming
Market Size in 2022 Market Forecast in 2030 CAGR (in %) Base Year
USD 1983.74 Million USD 4012.83 Million 9.18% 2022

Tissue Engineered Skin Substitute Market

Description

The global tissue engineered skin substitute market size was worth around USD 1983.74 Million in 2022 and is predicted to grow to around USD 4012.83 Million by 2030 with a compound annual growth rate (CAGR) of roughly 9.18% between 2023 and 2030. The report analyzes the global tissue engineered skin substitute market drivers, restraints/challenges, and the effect they have on the demands during the projection period. In addition, the report explores emerging opportunities in the tissue engineered skin substitute industry.

Tissue Engineered Skin Substitute Market SizeRequest Free Sample

Global Tissue Engineered Skin Substitute Market: Overview

Tissue engineering is a way for maintaining, improving, and restoring damaged tissues and organs. It utilizes a mixture of active biological molecules, cells, and scaffolds for developing various functional tissues. Such tissue engineering skin substitutes are a replacement for traditional tissue extraction and wound healing methods.

Global Tissue Engineered Skin Substitute Market: Growth Factors

One of the major factors driving the growth of the global tissue engineered skin substitute market is the growing technological advancements in the healthcare sector. Also, the growing prevalence of chronic and acute wounds in patients all across the globe is also fuelling the growth of the global tissue-engineered skin substitute market. Also, the growing incidents of accidents like burns, road accidents, and trauma events all across the globe are likely to augment the growth of the global tissue-engineered skin substitute market significantly during the forecast period.

The significant spike in demand for skin grafts is also fuelling the growth of the market globally. The skin graft is usually done in the treatment procedures of acute wounds. Synthetic and biosynthetic tissue engineered skin substitutes are utilized in the treatment of severe and moderate burns. Biological skin substitutes are utilized during surgical procedures for healing large wounds. The growing awareness regarding such treatment procedures among people all across the globe is also driving the growth of the market globally. Moreover, the growing demand for breast reconstruction is anticipated to boost the growth of the market globally. The growing investment activities for the development of dermo-epidermal and complex skin substitutes are also escalating the growth of the market globally during the forecast period.

Tissue-Engineered Skin Substitute MarketRequest Free Sample

Global Tissue Engineered Skin Substitute Market: Segmentation

The global tissue engineered skin substitute market can be segmented into end-users, application, products, and regions.

By end-user, the market can be segmented into wound care centers, hospitals, and others. The hospital segment accounts for the largest share in the global tissue engineered skin substitute market due to the growing number of surgeries all across the globe. Moreover, the growing cases of venous leg ulcers and diabetic foot ulcers are the key factors driving the growth of the segment vigorously. Also, the growing incidences of surgical wounds owing to a large number of ongoing surgeries across the world are also driving the growth of the segment.

By application, the market can be segmented into chronic and acute wounds. The acute wound segment holds the largest share in the global tissue engineered skin substitute market due to the growing number of surgeries along with a high prevalence of burn injuries. The acute wounds segment can further be bifurcated into burns, injuries, and surgeries & trauma. The chronic wound segment is anticipated to witness huge growth during the forecast period due to its wide applications in the treatment of extreme cases of venous leg ulcers, diabetic foot ulcers, and pressure ulcers. The chronic wound segment can further be bifurcated into venous leg ulcers, pressure ulcers, diabetic foot ulcers, and others.

By product, the market can be segmented into biological, biosynthetic, and synthetic. The biological segment dominates the global tissue engineered skin substitute market due to the growing prevalence of acute wounds all across the globe.

Tissue Engineered Skin Substitute Market: Report Scope

Report Attributes Report Details
Report Name Tissue Engineered Skin Substitute Market Research Report
Market Size in 2022 USD 1983.74 Million
Market Forecast in 2030 USD 4012.83 Million
Growth Rate CAGR of 9.18%
Number of Pages 214
Key Companies Covered AMARANTUS BIOSCIENCE HOLDINGS INC., Tissue Regenix, Mallinckrodt, ConvaTec Group PLC, BSN medical, BSN medical, Medline Industries Inc, Kerecis, LifeNet Health, MiMedx., Organogenesis Inc, Regenicin., Integra LifeSciences Corporation, Mölnlycke Health Care AB, and Smith & Nephew.
Segments Covered By Product, By Application, By End User, And By Region
Regions Covered North America, Europe, Asia Pacific (APAC), Latin America, Middle East, and Africa (MEA)
Base Year 2022
Historical Year 2017 to 2021
Forecast Year 2023 - 2030
Customization Scope Avail customized purchase options to meet your exact research needs. Request For Customization

Global Tissue Engineered Skin Substitute Market: Regional analysis

North America accounts for the largest share in the global tissue engineered skin substitute market due to the growing technological advancements in the region. The growing incidences of burn injuries in the region further boost the growth of the regional market.

Asia Pacific is anticipated to witness huge growth during the forecast period due to the presence of prominent market players in the region. Also, the growing efforts from government authorities to boost the healthcare infrastructure in the region further propel the growth of the regional market during the forecast period.

Global Tissue Engineered Skin Substitute Market: Competitive Players

  • AMARANTUS BIOSCIENCE HOLDINGS INC.
  • Tissue Regenix
  • Mallinckrodt
  • ConvaTec Group PLC
  • BSN medical
  • BSN medical
  • Medline Industries Inc
  • Kerecis
  • LifeNet Health
  • MiMedx
  • Organogenesis Inc
  • Regenicin
  • Integra LifeSciences Corporation
  • Mölnlycke Health Care AB
  • Smith & Nephew

Global Tissue Engineered Skin Substitute Market: Segment Analysis

By Product

  • Biological
  • Biosynthetic
  • Synthetic

By Application

  • Chronic
  • Acute Wounds

By End User

  • Wound Care Centers
  • Hospitals 
  • Others

By Region

  • North America

    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

What Reports Provides

  • Full in-depth analysis of the parent market
  • Important changes in market dynamics
  • Segmentation details of the market
  • Former, on-going, and projected market analysis in terms of volume and value
  • Assessment of niche industry developments
  • Market share analysis
  • Key strategies of major players
  • Emerging segments and regional markets
  • Testimonials to companies in order to fortify their foothold in the market.

Table Of Content

Choose License Type

  • zion payment modes

FrequentlyAsked Questions

Tissue engineering is a way for maintaining, improving, and restoring damaged tissues and organs. It utilizes a mixture of active biological molecules, cells, and scaffolds for developing various functional tissues. Such tissue engineering skin substitutes are a replacement for traditional tissue extraction and wound healing methods.

The global tissue engineered skin substitute market size was worth around USD 1983.74 Million in 2022 and is predicted to grow to around USD 4012.83 Million by 2030.

The CAGR value of the tissue engineered skin substitute market is expected to be around 9.18% during 2023-2030.

North America accounts for the largest share in the global tissue engineered skin substitute market due to the growing technological advancements in the region. The growing incidences of burn injuries in the region further boost the growth of the regional market.

The global tissue engineered skin substitute market is led by players like AMARANTUS BIOSCIENCE HOLDINGS INC., Tissue Regenix, Mallinckrodt, ConvaTec Group PLC, BSN medical, BSN medical, Medline Industries Inc, Kerecis, LifeNet Health, MiMedx., Organogenesis Inc, Regenicin., Integra LifeSciences Corporation, Mölnlycke Health Care AB, and Smith & Nephew.

One of the major factors driving the growth of the global tissue-engineered skin substitute market is the growing technological advancements in the healthcare sector. Also, the growing prevalence of chronic and acute wounds in patients all across the globe is also fuelling the growth of the global tissue-engineered skin substitute market.

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008

Contact #

US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

twitter

Industry Press Release

We Accept

We have secured system to process your transaction.

  • payment methods

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed